Wolford Dallas D, Fichera Alessandro
Division of Colorectal Surgery Department of Surgery Baylor University Medical Center Dallas Texas USA.
Ann Gastroenterol Surg. 2020 Jun 24;4(5):514-520. doi: 10.1002/ags3.12368. eCollection 2020 Sep.
Management of inflammatory bowel disease has evolved extensively in the last three decades. We have learnt a lot about the pathophysiology and natural history of the disease. New effective classes of drugs with the associated potential morbidity have been introduced. New surgical techniques have been popularized leading to a better understanding of the optimal timing of surgery. The result is a very complex subspecialty of gastroenterology and colorectal surgery called the "IBDologist." Only if we manage these complex patients in the context of a multi-disciplinary team will we be able to obtain outstanding outcomes, specifically with high and sustained remission rates for these patients.
在过去三十年中，炎症性肠病的管理发生了广泛演变。我们对该疾病的病理生理学和自然史有了很多了解。引入了具有相关潜在发病率的新型有效药物类别。新的外科技术得到普及，从而使人们对手术的最佳时机有了更好的理解。结果形成了胃肠病学和结直肠外科中一个非常复杂的亚专业，即“炎症性肠病专家”。只有在多学科团队的背景下管理这些复杂患者，我们才能取得出色的治疗效果，特别是使这些患者获得高且持续的缓解率。
